Page History

1. Is the Standard implemented in your Office's/Organization's practice? (Please choose one of the options below)

•  Completely
•  Partly
•  Not Implemented

2. If the answer was "Partly", please explain your Office's/Organization's practice briefly:

3. If the answer was "Not Implemented", does your Office/Organization plan to implement the Standard?

4. Comments (optional)

IPO currently examines biological sequence listings using the authoring tool CRF4 which was developed by the USPTO and is ST.25 compliant.
CIPO plans to upgrade to ST.26 for nucleotide and amino acid sequence listing when the replacement authoring tool becomes available.